Remdesivir for COVID-19: Why Not Dose Higher?

Yan, Victoria C; Muller, Florian L

Yan, Victoria C; Muller, Florian L.

Yan VC; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas, USA victoriacyanide@gmail.com.
Muller FL; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Antimicrob Agents Chemother ; 65(4)2021 03 18.

Article in English | MEDLINE | ID: covidwho-1166350

Subject(s)

Antiviral Agents; COVID-19 Drug Treatment; Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Antiviral Agents/therapeutic use; Humans; SARS-CoV-2

Keywords

COVID-19; GS-441524; drug metabolism; prodrug; remdesivir

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Drug Treatment Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Aac.02713-20

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google